A multi-centre prospective controlled trial comparing calcineurin inhibitor monotherapy with sirolimus monthotherapy in hepatitis C infected patients with hepatic fibrosis following liver transplantation
Phase of Trial: Phase IV
Latest Information Update: 16 Sep 2014
At a glance
- Drugs Sirolimus (Primary) ; Calcineurin inhibitors
- Indications Liver transplant rejection
- Focus Therapeutic Use
- 01 Dec 2013 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 17 Oct 2012 This study was discontinued before set-up in England, according to the UK Clinical trials Register.
- 14 May 2010 New source identified and integrated (ISRCTN: Current Controlled Trials record no. 26350966).